4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001567619-22-012842
10% owner acquired 4,466 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc 10% owner | 2022-06-10 | Grant or award | +4,466 | 5,235,954 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc 10% owner | 2022-06-10 | Grant or award · Stock Option (right to buy) | +14,550 | 14,550 | D: show line 2 in the form |
Loading xslF345X03/doc1.xml…